Comparison of Metered-Dose Inhaler Attached to an Aerochamber with an Updraft Nebulizer for the Administration of Metaproterenol in Hospitalized Patients

References

• Larsson S, Svedmyr N. Bronchodilating effect and side effects of beta 2 adrenoceptor stimulants by different modes of administration (tablets, me-tered dose aerosol, and combinations thereof). Am Rev Respir Dis 1977; 116: 861–869
   PubMed Web of Science ®Google Scholar
• Laurenco R, Cotromanes E. Clinical aerosols. Therapeutic aerosols. Arch Intern Med 1982; 142: 2299–2308
   PubMedGoogle Scholar
• Baum G, Wolinsky E. Textbook of Pulmonary Diseases, 3rd ed. Little, Brown, Boston 1983
   Google Scholar
• Snedecor G, Cochran W. Statistical Methods, 6th ed. Iowa State University Press, Ames, Iowa 1967; 100–116; 419–425
   Google Scholar
• Pavia D, Thompson M, Shannon H. Aerosol inhalation and depth of deposition in the human lung. Arch Environ Health 1977; 34: 131–137
   Google Scholar
• Newman S, Pavia D, Clarke S. How should a pressurized β-adrenergic bronchodilator be inhaled?. Eur J Respir Dis 1981; 62: 3–21
   PubMedGoogle Scholar
• Orehek J, Gayrard P, Grimaud C, Charpin J. Patient error in use of bronchodilator metered aerosols. Br Med J 1976; 1: 76
   Web of Science ®Google Scholar
• Shim C, Williams M. The adequacy of inhalation of aerosol from cannister nebulizers. Am J Med 1980; 69: 891–894
   PubMed Web of Science ®Google Scholar
• Epstein S, Manning C, Ashley M, Corey P. Survey of the clinical use of pressurized aerosol inhalers. Can Med Assoc J 1979; 120: 813–816
   PubMed Web of Science ®Google Scholar
• Paterson I, Crompton G. Use of pressurized aerosols by asthmatic patients. Br Med J 1976; 1: 76–77
   PubMed Web of Science ®Google Scholar
• Saunders K B. Misuse of inhaled bronchodilator agents. Br Med J 1965; 1: 1037–1038
   PubMed Web of Science ®Google Scholar
• Kelling J, Strohl K, Smith R, Altose M. Physician knowledge in the use of canister nebulizers. Chest 1983; 83: 612–614
   PubMed Web of Science ®Google Scholar
• Tobin M, Jenouri G, Ignasio D, Kim C, Watson H, Sackner M. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems. Am Rev Respir Dis 1982; 126: 670–675
   PubMed Web of Science ®Google Scholar
• Lindgren S B, Formgren H, Moren F. Improved aerosol therapy of asthma: Effect of actuator tube size on drug availability. Eur J Respir Dis 1980; 61: 56
   Google Scholar
• Dolovich M, Eng P, Ruffin R, Corr D, Newhouse M. Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest 1983; 84: 36–41
   PubMed Web of Science ®Google Scholar
• Newman S, Moren F, Pavia D, Little F, Clarke S. Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis 1981; 124: 317–320
   PubMed Web of Science ®Google Scholar
• Poppius H. Inhalation of terbutaline spray through an extended mouthpiece. Effect on central and peripheral airways. Respiration 1980; 40: 278–283
   PubMedGoogle Scholar
• Lulling J, Delwiche J P, Hidinger K G, Prignot J. Influence of different extension-actuator tubes on the bronchodilarion effect of a terbutaline sulfate aerosol. Eur J Respir Dis 1983; 64: 33–37
   PubMedGoogle Scholar
• Cushley M, Lewis R, Tattersfield A. Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax 1983; 38: 908–913
   PubMed Web of Science ®Google Scholar
• Godden D, Crompton G. An objective assessment of the tube spacer in patients unable to use a conventional pressurized aerosol efficiently. Br J Dis Chest 1981; 75: 165–168
   PubMedGoogle Scholar
• Gomm S, Keaney N, Winsey N, Stretton T. Effect of an extension tube on the bronchodilator efficacy of terbutaline delivered from a metered dose inhaler. Thorax 1980; 35: 552–556
   PubMedGoogle Scholar
• Corr D, Dolovich M, McCormack D, Ruffin R, Obminski G, Newhouse M. Design and characteristics of a portable breath activated particle size selective medical aerosol inhaler. J Aerosol Sci 1982; 13: 1–7
   Web of Science ®Google Scholar
• Corr D, Dolovich M, McCormack D, Ruffin R, Obminski G, Newhouse M. The Aerochamber: A new demand-inhalation device for delivery of aerosolized drugs. Am Rev Respir Dis 1980; 121: 123
   Google Scholar
• Epstein S, Parsons J, Corey P, Worsley G, Reilly P. A comparison of three means of pressurized aerosol inhaler use. Am Rev Respir Dis 1983; 128: 253–255
   PubMed Web of Science ®Google Scholar
• Gurwitz D, Levison H, Mindorff C, Reilly P, Worsley G. Assessment of a new device (Aerochamber) for use with aerosol drugs in asthmatic children. Ann Allergy 1983; 50: 166–170
   PubMedGoogle Scholar
• Hodges I GC, Milner A D, Stokes G M. Assessment of a new device for delivering aerosol drugs to asthmatic children. Arch Dis Child 1981; 56: 787–800
   PubMed Web of Science ®Google Scholar
• Pedersen S. Aerosol treatment of bronchoconstric-tion in children, with or without a tube spacer. N Engl J Med 1983; 308: 1328–1330
   PubMed Web of Science ®Google Scholar
• Kiellman N IM, Hidinger K G. Improved efficacy of pressurized terbutaline aerosol in childhood asthma using a spacer. Opusc Med 1981; 26: 47
   Google Scholar
• Ellul-Micallef R, Moren F, Wetterlin K, Hidinger K G. Use of a spacer inhaler attachment in asthmatic children. Thorax 1980; 35: 620
   PubMed Web of Science ®Google Scholar
• Stauder J, Hidinger K G. Terbutaline aerosol from a metered dose inhaler with a 750 ml spacer or as a nebulized solution. Respiration 1983; 44: 237–240
   PubMedGoogle Scholar
• Laursen L, Munch E, Weeke E, Hidinger K G. Comparison of a 750 ml spacer and a nebulizer in domicilary treatment of severe chronic asthma with terbutaline. Eur J Respir Dis 1983; 64: 498–503
   PubMedGoogle Scholar
• Toogood J H, Jennings B, Baskerville J, Newhouse M. Assessment of a device for reducing oropharyngeal complications during becla-methasone aerosol treatment of asthma. Am Rev Respir Dis 1981; 123: 113
   Google Scholar